Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel in refractory partial-onset seizures
NCT01618695Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2012
- Primary completion
- Sep 2014
- Modality
- Classical Binding Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of perampanel in focal onset seizure, sponsored by Eisai Co., Ltd.. Started May 2012; status: completed.
02
Drugs
perampanel
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT01618695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01618695.